Clinical Trials Search | Loyola Medicine

Study Title

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)

Study Contact

NCTID

NCT04267848

Recruitment Status

RECRUITING

Study Title

An Open Label Expanded Access Study of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Study Contact

NCTID

NCT04260698

Recruitment Status

COMPLETED

Study Title

Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism Using Pharmaco-mechanical Catheter Directed Thrombolysis for the redUction of Thrombus burdEn

Study Contact

NCTID

NCT04248868

Recruitment Status

COMPLETED

Study Title

AROMA Study: Anxiety Reduction During Office Procedural Medicine Using Aromatherapy

Study Contact

NCTID

NCT04260399

Recruitment Status

COMPLETED

Study Title

A Phase III Study of Consolidative Radiotherapy in Patients With Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)

Study Contact

Nataliya V Uboha - Role: CONTACT - Phone: 608-265-9966 - Email: Nvuboha@medicine.wisc.edu

NCTID

NCT04248452

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts

Study Contact

Michelle Durnan - Role: CONTACT - Phone: +44 141 343 0195 - Email: m.durnan@terumoaortic.com
Sammy Jassal - Role: CONTACT - Phone: +44 141 343 0195 - Email: s.dhaliwal@terumoaortic.com

NCTID

NCT04246463

Recruitment Status

RECRUITING

Study Title

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

Study Contact

David Kozono, MD, PhD - Role: CONTACT - Phone: 617-632-5734 - Email: dkozono@bwh.harvard.edu

NCTID

NCT04242095

Recruitment Status

RECRUITING

Study Title

Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)

Study Contact

NCTID

NCT04216290

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

Dose Escalation Study of CD19 Chimeric Antigen Receptor (CAR) T Cells With a CD34 Selection Marker in Adults With Recurrent or Refractory B Cell Malignancies

Study Contact

NCTID

NCT04214886

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

Study Contact

NCTID

NCT04214262

Recruitment Status

ACTIVE_NOT_RECRUITING